Atopic Dermatitis Composition with Plant Extracts for Long-Term Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for atopic dermatitis often require frequent administration and can have side effects, with limited persistence of therapeutic effects beyond treatment interruption.
Innovation Solution
A topical composition comprising effective amounts of extracts from Allium, Citrus, Paullinia, and Theobroma species, administered for a period necessary to detect therapeutic effects, which persist for at least 8 weeks to 24 weeks or more after the last administration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for atopic dermatitis are administered frequently, then therapeutic effects are maintained, but treatment complexity and patient burden increase
Solution Approach 1:
The patent changes the chemical parameters of the treatment composition by combining multiple plant extracts (Allium sativum, Citrus limon, Paullinia cupana, Theobroma cacao) with specific concentrations and formulations, thereby extending the duration of therapeutic effect and reducing administration frequency
Solution Approach 2:
The patent uses a composite formulation combining four different plant extracts together with excipients to create a synergistic composition that provides prolonged therapeutic effects, allowing less frequent application compared to single-ingredient treatments
2Reliability
If current treatments are administered continuously, then symptoms are controlled, but side effects accumulate
Solution Approach 1:
The patent employs natural plant extracts that are biodegradable and have short half-lives in the body, eliminating accumulation of harmful substances while maintaining effective symptom control through repeated short-term applications
Solution Approach 2:
The patent uses naturally occurring plant compounds that the body can metabolize and eliminate safely, converting potentially persistent synthetic drug risks into benign natural substances that provide therapeutic benefits without long-term harmful accumulation
3Reliability
If treatment duration is extended to maintain therapeutic effects, then symptom control improves, but patient compliance decreases
Solution Approach 1:
The patent enables periodic application intervals (e.g., once or twice daily) that are simple enough for patient compliance while the formulation ensures therapeutic effects persist between applications, creating an effective balance between duration and ease of use
Data Source
AI summary
The invention relates to methods of treatment and/or prevention of an inflammatory skin disease in a subject, wherein the therapeutic effects persist for at least 24 weeks or more after the last administration of the composition of the invention. Also disclosed are kits and methods of treating and/or preventing an inflammatory skin disease using said composition.